Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Completed · Phase 1

Conditions studied: Duchenne's Muscular Dystrophy

In brief

This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.

Key facts

Study ID

NCT02235844

Run by

Allergy and Asthma Consultants, Wichita, Kansas

People needed

1

Starts

2014-09-01

Expected to finish

2017-09-30

Last updated by the study team

2019-09-16

Who can join

Age: 28 and older, up to 31. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Duchenne's Muscular Dystrophy

You may not qualify if…

• None

Where it is running

• Asthma and Allergy Consultants — Wichita, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.